CDC20 and breast carcinoma: While the prognosis and survival outcomes show significant variation among different clinical subtypes, we then trained a Cox Regression model to investigate the correlation between Cdc20 expression and clinical outcomes, using the expression data and survival data from a study by the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC).